Grants and Contributions:
Title:
ARP - Feasibility - Development of an antimicrobial solution against Escherichia coli.
Agreement Number:
1029130
Agreement Value:
$75,000.00
Agreement Date:
Apr 14, 2025 - Nov 28, 2025
Description:
This project aims to develop an antimicrobial solution targeting coliforms in order to broaden the protective coverage against pathogenic food contaminants.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4P5
Reference Number:
172-2025-2026-Q1-1029130
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
712443522
Recipient Type:
For-profit organization
Recipient's Operating Name:
Innodal
Recipient's Legal Name:
Laboratoire Innodal inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325190